DE3905726A1
(de)
*
|
1989-02-24 |
1990-08-30 |
Hoechst Ag |
Druckgaspackung und treibmittel fuer aerosole
|
DE4003270A1
(de)
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
MX9203481A
(es)
*
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
EP0656205B1
(de)
*
|
1991-06-10 |
2001-08-08 |
Schering Corporation |
Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
|
DK0656206T3
(da)
†
|
1991-06-10 |
2001-10-08 |
Schering Corp |
Aerosolformuleringer uden chlorfluorcarbonforbindelser
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
ES2079210T3
(es)
*
|
1991-12-12 |
1996-01-01 |
Glaxo Group Ltd |
Formulacion farmaceutica de aerosol.
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
CA2125666C
(en)
|
1991-12-12 |
2002-07-16 |
Rachel Ann Akehurst |
Medicaments
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
AU675633B2
(en)
*
|
1991-12-18 |
1997-02-13 |
Minnesota Mining And Manufacturing Company |
Suspension aerosol formulations
|
EP0550031B1
(de)
*
|
1991-12-31 |
1996-05-08 |
Hoechst Aktiengesellschaft |
Medizinische Aerosolformulierung
|
US5833950A
(en)
*
|
1992-07-31 |
1998-11-10 |
Glaxo Group Limited |
Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
|
AU699677B2
(en)
*
|
1992-07-31 |
1998-12-10 |
Glaxo Group Limited |
Surfactant free aerosol formulations containing beclomathasone dipropionate
|
MX9304585A
(es)
*
|
1992-07-31 |
1994-03-31 |
Glaxo Group Ltd |
Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
|
RO117414B1
(ro)
*
|
1992-12-09 |
2002-03-29 |
Jager Paul D Waterbury |
Compozitie farmaceutica de aerosol in solutie
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
DE4322703A1
(de)
*
|
1993-07-08 |
1995-01-12 |
Asta Medica Ag |
Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
|
DE69424181T2
(de)
*
|
1993-12-20 |
2000-10-19 |
Minnesota Mining And Mfg. Co., Saint Paul |
Flunisolide aerosolformulierungen
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
PE44995A1
(es)
*
|
1994-01-27 |
1995-12-18 |
Schering Corp |
Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
|
JPH09510445A
(ja)
*
|
1994-03-14 |
1997-10-21 |
アボツト・ラボラトリーズ |
ビタミンe含有エアゾル医薬組成物
|
US5508023A
(en)
*
|
1994-04-11 |
1996-04-16 |
The Center For Innovative Technology |
Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US5635159A
(en)
*
|
1994-08-26 |
1997-06-03 |
Abbott Laboratories |
Aerosol drug formulations containing polyglycolyzed glycerides
|
US5983956A
(en)
|
1994-10-03 |
1999-11-16 |
Astra Aktiebolag |
Formulation for inhalation
|
US5980949A
(en)
*
|
1994-10-03 |
1999-11-09 |
Astra Aktiebolag |
Formulation for inhalation
|
GB9425160D0
(en)
*
|
1994-12-10 |
1995-02-08 |
Glaxo Group Ltd |
Medicaments
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
EP0806940B1
(de)
*
|
1994-12-22 |
2003-04-09 |
AstraZeneca AB |
Aerosol-arzneiformulierungen
|
US6013245A
(en)
*
|
1995-01-26 |
2000-01-11 |
Glaxo Group Limited |
Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
MX9800125A
(es)
*
|
1995-06-27 |
1998-03-31 |
Boehringer Ingelheim Kg |
Nuevas composiciones medicinales estables para generar aerosoles libres de gas propulsor.
|
US5690910A
(en)
*
|
1995-08-18 |
1997-11-25 |
Baker Norton Pharmaceuticals, Inc. |
Method for treating asthma
|
US5955098A
(en)
*
|
1996-04-12 |
1999-09-21 |
Flemington Pharmaceutical Corp. |
Buccal non polar spray or capsule
|
DE19616573C2
(de)
|
1996-04-25 |
1999-03-04 |
Pari Gmbh |
Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
|
WO1997042958A1
(en)
*
|
1996-05-09 |
1997-11-20 |
Amrad Operations Pty. Ltd. |
Treatment of asthma and airway diseases
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9612297D0
(en)
*
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
NZ334112A
(en)
*
|
1996-08-29 |
2000-07-28 |
Schering Corp |
Aerosol formulation comprising 1,1,1,2,3,3,3-heptafluoropropane, mometasone furoate and ethanol
|
US6068832A
(en)
*
|
1996-08-29 |
2000-05-30 |
Schering Corporation |
Chlorofluorocarbon-free mometasone furoate aerosol formulations
|
US6039932A
(en)
*
|
1996-09-27 |
2000-03-21 |
3M Innovative Properties Company |
Medicinal inhalation aerosol formulations containing budesonide
|
DE69732306T2
(de)
*
|
1997-01-16 |
2006-01-12 |
Massachusetts Institute Of Technology, Cambridge |
Zubereitung von partikelhaltigen arzneimitteln zur inhalation
|
EP1498115A1
(de)
*
|
1997-01-16 |
2005-01-19 |
Massachusetts Institute Of Technology |
Zubereitung von partikelhaltigen Arzneimitteln zur Inhalation
|
SE9700135D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
US6349719B2
(en)
|
1997-02-24 |
2002-02-26 |
Aradigm Corporation |
Formulation and devices for monitoring the efficacy of the delivery of aerosols
|
US6192882B1
(en)
*
|
1997-02-24 |
2001-02-27 |
Aradigm Corporation |
Formulation and devices for monitoring the efficacy of the delivery of aerosols
|
US6284226B1
(en)
*
|
1997-03-14 |
2001-09-04 |
Fujisawa Pharmaceutical Co., Ltd. |
Aerosol composition containing middle-chain fatty acid triglyceride dispersant
|
US6503537B2
(en)
|
1997-03-20 |
2003-01-07 |
Schering Corporation |
Preparation of powder agglomerates
|
US6495167B2
(en)
|
1997-03-20 |
2002-12-17 |
Schering Corporation |
Preparation of powder agglomerates
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
GB2326334A
(en)
†
|
1997-06-13 |
1998-12-23 |
Chiesi Farma Spa |
Pharmaceutical aerosol compositions
|
US5925334A
(en)
*
|
1997-08-27 |
1999-07-20 |
Rubin; Bruce K. |
Use of surface active agents to promote mucus clearance
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
ATE238035T1
(de)
*
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
Perforierte mikropartikel und deren verwendung
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
CA2306024C
(en)
*
|
1997-10-01 |
2011-04-26 |
Flemington Pharmaceutical Corporation |
Buccal, polar and non-polar spray or capsule
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US7632517B2
(en)
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US6086376A
(en)
*
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
US8466134B1
(en)
|
1998-06-26 |
2013-06-18 |
Athena Neurosciences, Inc. |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US6485747B1
(en)
*
|
1998-10-30 |
2002-11-26 |
Monsanto Company |
Coated active tablet(s)
|
US6261539B1
(en)
*
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
AU5397300A
(en)
*
|
1999-06-02 |
2000-12-28 |
Hexal Ag |
Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
JP2003511417A
(ja)
*
|
1999-10-08 |
2003-03-25 |
シェーリング コーポレイション |
局所的鼻疾患治療
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US6610271B2
(en)
*
|
2000-05-10 |
2003-08-26 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of lorazepam
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20020085978A1
(en)
*
|
2000-11-10 |
2002-07-04 |
Mina Buenafe |
Degradation-resistant glucocorticosteroid formulations
|
EP1345629A2
(de)
|
2000-12-29 |
2003-09-24 |
Advanced Inhalation Research, Inc. |
Inhalationspartikel mit verzögerter freigabe
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
US20040176359A1
(en)
*
|
2001-02-20 |
2004-09-09 |
University Of Kentucky Research Foundation |
Intranasal Benzodiazepine compositions
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
AR036358A1
(es)
*
|
2001-08-28 |
2004-09-01 |
Schering Corp |
Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
WO2003053411A1
(en)
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
ATE353231T1
(de)
*
|
2002-08-23 |
2007-02-15 |
Schering Corp |
Pharmazeutische zusammensetzungen
|
EP1785156B1
(de)
*
|
2002-08-23 |
2012-06-27 |
Schering Corporation |
Aerosolhaltiger pharmazeutischer Dosierinhalator
|
EP1878664B1
(de)
*
|
2002-08-27 |
2011-03-30 |
Schering Corporation |
Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
|
JP4755495B2
(ja)
*
|
2002-12-12 |
2011-08-24 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
組合せ医薬品
|
EP1635845A1
(de)
*
|
2003-06-13 |
2006-03-22 |
ALTANA Pharma AG |
Kombination aus formoterol und ciclesonid
|
DK1670482T4
(da)
*
|
2003-09-16 |
2022-08-22 |
Covis Pharma B V |
Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
|
US20050136009A1
(en)
*
|
2003-10-20 |
2005-06-23 |
Schering Corporation |
Pharmaceutical compositions
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
CA2554064A1
(en)
|
2004-01-21 |
2005-08-11 |
Schering Corporation |
Treatment methods
|
US20050287077A1
(en)
*
|
2004-02-10 |
2005-12-29 |
James E. Shipley |
Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon
|
EP1732527A2
(de)
*
|
2004-03-17 |
2006-12-20 |
Mpex Pharmaceuticals, Inc. |
Verwendung und verabreichung von bakteriellen ausfluss-pumpenhemmern
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
US20070134165A1
(en)
*
|
2004-04-20 |
2007-06-14 |
Altana Pharma Ag |
Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
|
WO2005115520A1
(en)
*
|
2004-05-20 |
2005-12-08 |
Discovery Laboratories, Inc. |
Methods , systems and devices for noninvasive pulmonary delivery
|
US20060014698A1
(en)
*
|
2004-07-14 |
2006-01-19 |
O'connor Michael F |
Nebulized pharmaceutical compositions for the treatment of bronchial disorders
|
MX2007001561A
(es)
*
|
2004-08-04 |
2007-04-16 |
Schering Corp |
Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
|
JP2006087815A
(ja)
*
|
2004-09-27 |
2006-04-06 |
Canon Inc |
噴霧方法および該方法に基づく噴霧装置
|
US8028697B2
(en)
|
2005-04-28 |
2011-10-04 |
Trudell Medical International |
Ventilator circuit and method for the use thereof
|
US7838532B2
(en)
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
CA2607148C
(en)
|
2005-05-18 |
2014-12-23 |
Nektar Therapeutics |
Valves, devices, and methods for endobronchial therapy
|
BRPI0616642A2
(pt)
|
2005-09-29 |
2011-06-28 |
Nektar Therapeutics |
formulações de antibióticos, doses unitárias, kits e métodos
|
CA2641605A1
(en)
*
|
2006-02-09 |
2007-08-23 |
Schering Corporation |
Pharmaceutical formulations
|
JP2009526062A
(ja)
*
|
2006-02-09 |
2009-07-16 |
シェーリング コーポレイション |
薬学的処方物
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
WO2008025560A1
(en)
*
|
2006-09-01 |
2008-03-06 |
Pari Pharma Gmbh |
Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
|
US20080275030A1
(en)
|
2007-01-19 |
2008-11-06 |
Sveinbjorn Gizurarson |
Methods and Compositions for the Delivery of a Therapeutic Agent
|
EP2120875B1
(de)
|
2007-02-11 |
2018-07-11 |
Map Pharmaceuticals Inc. |
Verfahren zur therapeutischen verabreichung von dhe zur schnellen linderung von migräne bei gleichzeitiger minimierung von nebenwirkungsprofilen
|
RU2463084C2
(ru)
|
2008-03-17 |
2012-10-10 |
Дискавери Лабораториз, Инк. |
Адаптер дыхательного контура и система проксимальной доставки аэрозоля
|
HUE050147T2
(hu)
|
2008-10-07 |
2020-11-30 |
Horizon Orphan Llc |
Tüdõgyulladás csökkentése levofloxacin belélegzése útján
|
CN102202649A
(zh)
|
2008-10-07 |
2011-09-28 |
Mpex医药有限公司 |
用于改进的药物动力学的氟喹诺酮气雾剂制剂
|
CA2905402C
(en)
|
2008-10-22 |
2017-02-28 |
Trudell Medical International |
Modular aerosol delivery system
|
PT2473170T
(pt)
|
2009-09-04 |
2019-08-23 |
Horizon Orphan Llc |
Utilização de levofloxacina em aerossol para tratamento de fibrose cística
|
TWI399202B
(zh)
|
2011-03-17 |
2013-06-21 |
Intech Biopharm Ltd |
製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
|
CN106942784A
(zh)
*
|
2017-04-14 |
2017-07-14 |
张玲 |
一种七氟代‑3‑甲氧基丙烷组合物
|
WO2023198757A1
(en)
|
2022-04-14 |
2023-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections
|